Symptomatic hypocalcemia after sodium phosphate preparation in an adult with asymptomatic hypoparathyroidism.
Sodium phosphate is widely used as a bowel cleansing preparation. Its use is, however, not without risk. It can induce serious adverse effects like hypocalcemia, hyperphosphatemia and renal failure. In this case, a 75-year-old woman without known contraindications developed hypocalcemic tetany, hyperphosphatemia and renal failure after oral sodium phosphate. Asymptomatic hypoparathyroidism owing to previous thyroid surgery was identified as a new contributing risk factor for this complication.
Niemeijer
Nicolasine D
ND
Department of aInternal Medicine, Amphia Hospital, Breda, The Netherlands.
Rijk
Marno C
MC
van Guldener
Coen
C
D000367:Age Factors; D000368:Aged; D002400:Cathartics / Q000009:adverse effects*; D003113:Colonoscopy; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced* / Q000628:therapy; D007011:Hypoparathyroidism / Q000150:complications* / Q000601:surgery; D010710:Phosphates / Q000009:adverse effects*; D011300:Preoperative Care; D013965:Thyroidectomy / Q000009:adverse effects*; D016896:Treatment Outcome
D002400:Cathartics; D010710:Phosphates; C018279:sodium phosphate